Skip to main content
Clinical Trials/NCT05063279
NCT05063279
Completed
N/A

Resistance Training for Life - the Efficacy of Increasing Resistance Training Volume for Improving Muscle Mass, Function, Biology and Health in Young and Elderly

Stian Ellefsen1 site in 1 country76 target enrollmentSeptember 6, 2021
ConditionsSarcopenia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sarcopenia
Sponsor
Stian Ellefsen
Enrollment
76
Locations
1
Primary Endpoint
Muscle size, lower extremities
Status
Completed
Last Updated
last year

Overview

Brief Summary

Sarcopenia is an age-related gradual loss of muscle mass and strength and is associated with physical disability and mortality risk. Currently, the most promising remedy for preventing and treating sarcopenia is physical activity, particularly progressive resistance training. Yet, the amount of resistance exercise needed to achieve optimal benefits remains largely unknown. This lack of knowledge is underpinned by the notion that aging reduces the ability to adapt to (and benefit from) resistance training, and is further complicated by a relative large degrees of between-subject heterogeneity. The primary aim of the study is to compare the effects of 10 weeks of resistance training with low- and moderate volume (one vs. three sets per exercise) on muscle mass accretion in lower and upper body extremities in young (<30 years of age) and elderly individuals (>70 years of age). Specifically, the study addresses the hypothesis that elderly individuals will benefit more from higher exercise volume (moderate vs. low) compared to their young counterparts. In addition, the study aims to compare the efficacy of the two volume conditions for altering other characteristics such as muscle strength and biology, including assessment of associations between individual changes in muscle mass, strength and biology (e.g. the relationship between muscle mass accretion and muscle content of rRNA/rDNA), and also to investigate the general health effects of the intervention.

Registry
clinicaltrials.gov
Start Date
September 6, 2021
End Date
December 31, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Stian Ellefsen
Responsible Party
Sponsor Investigator
Principal Investigator

Stian Ellefsen

Professor

Inland Norway University of Applied Sciences

Eligibility Criteria

Inclusion Criteria

  • Ages between 18 and 30 or \> 70

Exclusion Criteria

  • Resistance training, \> 1 session per week
  • Endurance training, \> 3 sessions per week
  • Unstable cardiovascular disease
  • Illness or serious injury contradicting resistance training
  • Serious mental illness
  • Allergy to local anaesthesia

Outcomes

Primary Outcomes

Muscle size, lower extremities

Time Frame: Change from baseline to after the training period (10-12 weeks)

Muscle size of lower extremity knee extensors measured with magnetic resonance imaging (MRI).

Secondary Outcomes

  • Muscular peak power/force, lower-body extremities(MeasurChange from baseline to after the training period (10-12 weeks))
  • Muscle size, upper-body extremities(Change from baseline to after the training period (10-12 weeks))
  • Appendicular lean mass, lower-body extremities(Change from baseline to after the training period (10-12 weeks))
  • Appendicular lean mass, upper-body extremities(Change from baseline to after the training period (10-12 weeks))
  • Muscle thickness, m. vastus lateralis(Change from baseline to after the training period (10-12 weeks))
  • Muscle strength, lower-body extremities(Change from baseline to after the training period (10-12 weeks))
  • Muscle strength, upper-body extremities(Change from baseline to after the training period (10-12 weeks))

Study Sites (1)

Loading locations...

Similar Trials